Alberta Investment Management Corp (AIMCo)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,000	Closed	-$1.15M	–	1248
2023 Q2	$1.15M	Buy	+30,000	New	+$770K	0.01%	716
2016 Q3	–	Sell	-5,560	Closed	-$314K	–	792
2016 Q2	$314K	Buy	+5,560	New	+$338K	﹤0.01%	616

Alberta Investment Management Corp (AIMCo)'s KDNY Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 30,000 shares — an estimated $1.15M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in KDNY in Q2 2016 and held it in 2 quarters. The position peaked at $1.15M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 30,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.15M.
Alberta Investment Management Corp (AIMCo) first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
Alberta Investment Management Corp (AIMCo)'s Chinook Therapeutics, Inc. Common Stock position peaked at $1.15M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.